OBJECTIVES: We evaluated the validity and reliability of ultrasonography measurement of rectus femoris cross-sectional area compared to computed tomography in patients in pre-dialysis chronic kidney disease and analyzed the association between these measurements and the diagnosis of sarcopenia. METHODS: One hundred patients with nondialysis chronic kidney disease were evaluated. Sarcopenia was defined using the criteria of the Foundation for the National Institutes of Health Sarcopenia Project (FNIH). The rectus femoris cross-sectional area was evaluated using ultrasonography and computed tomography. RESULTS: The prevalence of sarcopenia was 29% according to the FNIH criteria. The difference in mean rectus femoris cross-secti...
Assessment of muscle mass (MM) or its proxies, lean tissue mass (LTM) or fat-free mass (FFM), is an ...
Skeletal muscle wasting has gained interest as a primary consequence of chronic kidney disease (CKD)...
Objectives: Using the new European Working Group on Sarcopenia in Older People (EWGSOP2) criteria, w...
OBJECTIVES: We evaluated the validity and reliability of ultrasonography measurement of rectus femor...
ObjectivesPatients with chronic kidney disease (CKD) have aberrant changes in body composition, incl...
BACKGROUND & AIM: Sarcopenia is defined as a loss of muscle mass and function, which can be caus...
Chronic kidney disease (CKD) is a catabolic condition associated with muscle wasting and dysfunction...
Muscle wasting is a frequent finding in patients with chronic kidney disease (CKD), especially in th...
[Background] Sarcopenia is a major health issue especially in patients on maintenance hemodialysis. ...
Muscle depletion and sarcopenic obesity are related to a higher morbimortality risk in chronic kidne...
Background/Objectives Estimation of muscle mass is an integral part of nutritional assessment in End...
International audienceSarcopenia is a well-known complication of protein energy wasting in hemodialy...
Main problem: In patients with Acute Kidney Injury there is a lack of nutritional variables that can...
Background: In chronic kidney disease (CKD), multiple metabolic and nutritional abnormalities contri...
This study aimed to assess muscle wasting and risk of protein energy wasting (PEW) in hemodialysis (...
Assessment of muscle mass (MM) or its proxies, lean tissue mass (LTM) or fat-free mass (FFM), is an ...
Skeletal muscle wasting has gained interest as a primary consequence of chronic kidney disease (CKD)...
Objectives: Using the new European Working Group on Sarcopenia in Older People (EWGSOP2) criteria, w...
OBJECTIVES: We evaluated the validity and reliability of ultrasonography measurement of rectus femor...
ObjectivesPatients with chronic kidney disease (CKD) have aberrant changes in body composition, incl...
BACKGROUND & AIM: Sarcopenia is defined as a loss of muscle mass and function, which can be caus...
Chronic kidney disease (CKD) is a catabolic condition associated with muscle wasting and dysfunction...
Muscle wasting is a frequent finding in patients with chronic kidney disease (CKD), especially in th...
[Background] Sarcopenia is a major health issue especially in patients on maintenance hemodialysis. ...
Muscle depletion and sarcopenic obesity are related to a higher morbimortality risk in chronic kidne...
Background/Objectives Estimation of muscle mass is an integral part of nutritional assessment in End...
International audienceSarcopenia is a well-known complication of protein energy wasting in hemodialy...
Main problem: In patients with Acute Kidney Injury there is a lack of nutritional variables that can...
Background: In chronic kidney disease (CKD), multiple metabolic and nutritional abnormalities contri...
This study aimed to assess muscle wasting and risk of protein energy wasting (PEW) in hemodialysis (...
Assessment of muscle mass (MM) or its proxies, lean tissue mass (LTM) or fat-free mass (FFM), is an ...
Skeletal muscle wasting has gained interest as a primary consequence of chronic kidney disease (CKD)...
Objectives: Using the new European Working Group on Sarcopenia in Older People (EWGSOP2) criteria, w...